{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:01:32Z","timestamp":1781830892898,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.02.083","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:14:36Z","timestamp":1300302876000},"page":"3714-3723","source":"Crossref","is-referenced-by-count":17,"title":["Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Jie","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.02.083_bib0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"November (5 Suppl. 1)","key":"10.1016\/j.vaccine.2011.02.083_bib0010","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.vaccine.2011.02.083_bib0015","first-page":"103","article-title":"Clinical significance of hepatitis C virus genotypes and quasispecies","volume":"20","author":"Farci","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.vaccine.2011.02.083_bib0020","first-page":"261","article-title":"Hepatitis C virus population dynamics during infection","volume":"299","author":"Pawlotsky","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02970148","article-title":"The hepatitis C virus persistence: how to evade the immune system?","volume":"28","author":"Pavio","year":"2003","journal-title":"J Biosci"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.02.083_bib0030","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.02.083_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2008.03.525","article-title":"Immune responses during acute and chronic infection with hepatitis C virus","volume":"128","author":"Ishii","year":"2008","journal-title":"Clin Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.02.083_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1515\/BC.2008.061","article-title":"Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine","volume":"389","author":"Thimme","year":"2008","journal-title":"Biol Chem"},{"issue":"August (17)","key":"10.1016\/j.vaccine.2011.02.083_bib0045","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","article-title":"Sequence analysis of the core gene of 14 hepatitis C virus genotypes","volume":"91","author":"Bukh","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<239::AID-JMV9>3.0.CO;2-V","article-title":"Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals","volume":"58","author":"Jackson","year":"1999","journal-title":"J Med Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.02.083_bib0055","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/infdis\/173.4.808","article-title":"Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees","volume":"173","author":"Wang","year":"1996","journal-title":"J Infect Dis"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.02.083_bib0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2893.2002.00373.x","article-title":"Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees","volume":"9","author":"Shata","year":"2002","journal-title":"J Viral Hepat"},{"issue":"November (24)","key":"10.1016\/j.vaccine.2011.02.083_bib0065","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2011.02.083_bib0070","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2011.02.083_bib0075","doi-asserted-by":"crossref","first-page":"43479","DOI":"10.1074\/jbc.M407640200","article-title":"Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation","volume":"279","author":"Eisen-Vandervelde","year":"2004","journal-title":"J Biol Chem"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.02.083_bib0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.transproceed.2004.12.293","article-title":"HCV core protein augments cyclosporine immunosuppression","volume":"37","author":"Kimball","year":"2005","journal-title":"Transplant Proc"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.02.083_bib0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2005.11.020","article-title":"gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core\/gC1qR-mediated T cell suppression in the outcome of HCV infection","volume":"346","author":"Yao","year":"2006","journal-title":"Virology"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.02.083_bib0090","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","article-title":"Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection","volume":"177","author":"Dolganiuc","year":"2006","journal-title":"J Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.02.083_bib0095","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1189\/jlb.0507268","article-title":"HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production","volume":"82","author":"Waggoner","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/vim.2006.0112","article-title":"Efficient induction of mouse immune responses to hepatitis C virus by viral core protein-carrying attenuated Salmonella typhimurium","volume":"20","author":"Liao","year":"2007","journal-title":"Viral Immunol"},{"issue":"October (41)","key":"10.1016\/j.vaccine.2011.02.083_bib0105","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1073\/pnas.0705522104","article-title":"Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus","volume":"104","author":"Johansson","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.02.083_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2011.02.083_bib0115","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J Virol"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2011.02.083_bib0120","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.3748\/wjg.v13.i36.4824","article-title":"Neutralizing antibodies in hepatitis C virus infection","volume":"13","author":"Zeisel","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2011.02.083_bib0125","first-page":"1","article-title":"Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies","volume":"317","author":"Keck","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.8.3.333","article-title":"Development of hepatitis C virus vaccines: challenges and progress","volume":"8","author":"Stoll-Keller","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.02.083_bib0135","first-page":"135","article-title":"Folding, assembly and subcellular localization of hepatitis C virus glycoproteins","volume":"242","author":"Dubuisson","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2011.02.083_bib0140","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1099\/0022-1317-82-11-2589","article-title":"Biogenesis of hepatitis C virus envelope glycoproteins","volume":"82","author":"Op De Beeck","year":"2001","journal-title":"J Gen Virol"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2011.02.083_bib0145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1099\/vir.0.008300-0","article-title":"Hepatitis C virus cell entry: role of lipoproteins and cellular receptors","volume":"90","author":"Burlone","year":"2009","journal-title":"J Gen Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2011.02.083_bib0150","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1128\/JVI.02642-06","article-title":"Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C","volume":"81","author":"Lavillette","year":"2007","journal-title":"J Virol"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.02.083_bib0155","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood.V92.9.3172","article-title":"Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma","volume":"92","author":"Paglia","year":"1998","journal-title":"Blood"},{"issue":"July (28\u201329)","key":"10.1016\/j.vaccine.2011.02.083_bib0160","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/S0264-410X(01)00109-8","article-title":"Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA","volume":"19","author":"Mollenkopf","year":"2001","journal-title":"Vaccine"},{"issue":"November (3\u20134)","key":"10.1016\/j.vaccine.2011.02.083_bib0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0264-410X(01)00355-3","article-title":"Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy","volume":"20","author":"Koesling","year":"2001","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.02.083_bib0170","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/hum.2007.053","article-title":"Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium","volume":"18","author":"Xie","year":"2007","journal-title":"Hum Gene Ther"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0175","first-page":"266","article-title":"Enhancement by an in vivo-activated promoter of immunogenicity of recombinant attenuated Salmonella typhimurium expressing hepatitis C virus core antigen","volume":"35","author":"Zhao","year":"2003","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K","article-title":"A model for the hepatitis C virus envelope glycoprotein E2","volume":"40","author":"Yagnik","year":"2000","journal-title":"Proteins"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.02.083_bib0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.02.083_bib0190","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2011.02.083_bib0195","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1016\/j.vaccine.2007.08.053","article-title":"Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies","volume":"25","author":"Stamataki","year":"2007","journal-title":"Vaccine"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2011.02.083_bib0200","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1073\/pnas.0703039104","article-title":"Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02970149","article-title":"Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses","volume":"28","author":"Mondelli","year":"2003","journal-title":"J Biosci"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.02.083_bib0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(01)00180-2","article-title":"Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?","volume":"52","author":"Mondelli","year":"2001","journal-title":"Antiviral Res"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.02.083_bib0215","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0225","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.158.3.1231","article-title":"Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids","volume":"158","author":"Geissler","year":"1997","journal-title":"J Immunol"},{"issue":"August (23\u201324)","key":"10.1016\/j.vaccine.2011.02.083_bib0230","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/S0264-410X(99)00130-9","article-title":"Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization","volume":"17","author":"Hu","year":"1999","journal-title":"Vaccine"},{"issue":"April (13\u201314)","key":"10.1016\/j.vaccine.2011.02.083_bib0235","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.vaccine.2003.09.047","article-title":"Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells","volume":"22","author":"Isaguliants","year":"2004","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.02.083_bib0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00705-002-0935-y","article-title":"CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization","volume":"148","author":"Encke","year":"2003","journal-title":"Arch Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.02.083_bib0245","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/IAI.66.6.2401-2409.1998","article-title":"Bacterial perturbation of cytokine networks","volume":"66","author":"Wilson","year":"1998","journal-title":"Infect Immun"},{"issue":"8\u201310","key":"10.1016\/j.vaccine.2011.02.083_bib0250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10611860410001670053","article-title":"Attenuated salmonella and Shigella as carriers for DNA vaccines","volume":"11","author":"Xu","year":"2003","journal-title":"J Drug Target"},{"issue":"April","key":"10.1016\/j.vaccine.2011.02.083_bib0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-065X.2008.00613.x","article-title":"Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis","volume":"222","author":"Xiang","year":"2008","journal-title":"Immunol Rev"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.02.083_bib0260","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/IAI.67.10.5133-5141.1999","article-title":"Use of in vivo-regulated promoters to deliver antigens from attenuated salmonella enterica var. Typhimurium","volume":"67","author":"Dunstan","year":"1999","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.02.083_bib0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81003-X","article-title":"Mg2+ as an extracellular signal: environmental regulation of Salmonella virulence","volume":"84","author":"Garcia Vescovi","year":"1996","journal-title":"Cell"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.02.083_bib0270","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.20934","article-title":"Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee","volume":"42","author":"Youn","year":"2005","journal-title":"Hepatology"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.02.083_bib0275","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.02.083_bib0280","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/JVI.72.7.6271-6276.1998","article-title":"Evolution of hypervariable region 1 of hepatitis C virus in primary infection","volume":"72","author":"Manzin","year":"1998","journal-title":"J Virol"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.02.083_bib0285","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J Virol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.02.083_bib0290","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J Virol"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2011.02.083_bib0295","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1099\/vir.0.83065-0","article-title":"Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33","volume":"88","author":"Tarr","year":"2007","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T07:17:40Z","timestamp":1712301460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":59,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11003318"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.02.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}